108 related articles for article (PubMed ID: 19139285)
21. Live Imaging of Host-Parasite Interactions in a Zebrafish Infection Model Reveals Cryptococcal Determinants of Virulence and Central Nervous System Invasion.
Tenor JL; Oehlers SH; Yang JL; Tobin DM; Perfect JR
mBio; 2015 Sep; 6(5):e01425-15. PubMed ID: 26419880
[TBL] [Abstract][Full Text] [Related]
22. Preclinical testing of radiopharmaceuticals for novel applications in HIV, bacterial and fungal infectious diseases.
Shah M; Garg G; Dadachova E
Q J Nucl Med Mol Imaging; 2015 Sep; 59(3):317-26. PubMed ID: 26200222
[TBL] [Abstract][Full Text] [Related]
23. Proven pulmonary cryptococcosis due to capsule-deficient Cryptococcus neoformans does not differ clinically from proven pulmonary cryptococcosis due to capsule-intact Cr. neoformans.
Torres HA; Prieto VG; Raad II; Kontoyiannis DP
Mycoses; 2005 Jan; 48(1):21-4. PubMed ID: 15679661
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of host immune responses to pulmonary cryptococcosis using a temperature-sensitive C. neoformans calcineurin A mutant strain.
Wormley FL; Cox GM; Perfect JR
Microb Pathog; 2005; 38(2-3):113-23. PubMed ID: 15748813
[TBL] [Abstract][Full Text] [Related]
25. Persistence of infection in mice inoculated intranasally with Cryptococcus neoformans.
Anderson DA; Sagha HM
Mycopathologia; 1988 Dec; 104(3):163-9. PubMed ID: 3070384
[TBL] [Abstract][Full Text] [Related]
26. Melanization of Cryptococcus neoformans affects lung inflammatory responses during cryptococcal infection.
Mednick AJ; Nosanchuk JD; Casadevall A
Infect Immun; 2005 Apr; 73(4):2012-9. PubMed ID: 15784542
[TBL] [Abstract][Full Text] [Related]
27. The pathology of human and murine pulmonary infection with Cryptococcus neoformans var. gattii.
Torda A; Kumar RK; Jones PD
Pathology; 2001 Nov; 33(4):475-8. PubMed ID: 11827415
[TBL] [Abstract][Full Text] [Related]
28. CD4
Neal LM; Xing E; Xu J; Kolbe JL; Osterholzer JJ; Segal BM; Williamson PR; Olszewski MA
mBio; 2017 Nov; 8(6):. PubMed ID: 29162707
[No Abstract] [Full Text] [Related]
29. Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Thailand display diverse phenotypic interactions with macrophages.
Hansakon A; Mutthakalin P; Ngamskulrungroj P; Chayakulkeeree M; Angkasekwinai P
Virulence; 2019 Dec; 10(1):26-36. PubMed ID: 30520685
[TBL] [Abstract][Full Text] [Related]
30. Cell wall targeting of laccase of Cryptococcus neoformans during infection of mice.
Waterman SR; Hacham M; Panepinto J; Hu G; Shin S; Williamson PR
Infect Immun; 2007 Feb; 75(2):714-22. PubMed ID: 17101662
[TBL] [Abstract][Full Text] [Related]
31. Experimental systemic infection with Cryptococcus neoformans var. grubii and Cryptococcus gattii in normal and immunodeficient mice.
Capilla J; Maffei CM; Clemons KV; Sobel RA; Stevens DA
Med Mycol; 2006 Nov; 44(7):601-10. PubMed ID: 17071553
[TBL] [Abstract][Full Text] [Related]
32. The role of macrophage inflammatory protein-1 alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection.
Olszewski MA; Huffnagle GB; McDonald RA; Lindell DM; Moore BB; Cook DN; Toews GB
J Immunol; 2000 Dec; 165(11):6429-36. PubMed ID: 11086082
[TBL] [Abstract][Full Text] [Related]
33. Cerebral cryptococcomas in a cow.
Magalhães GM; Saut JP; Beninati T; Medeiros AA; Queiroz GR; Tsuruta SA; Krockenberger M; Headley SA
J Comp Pathol; 2012; 147(2-3):106-10. PubMed ID: 22520822
[TBL] [Abstract][Full Text] [Related]
34. Cryptococcus neoformans Chitin Synthase 3 Plays a Critical Role in Dampening Host Inflammatory Responses.
Hole CR; Lam WC; Upadhya R; Lodge JK
mBio; 2020 Feb; 11(1):. PubMed ID: 32071275
[No Abstract] [Full Text] [Related]
35. Cutaneous cryptococcal infection as a manifestation of disseminated disease. Cryptococcus neoformans.
Lee JJ; Hsia RY
Ann Emerg Med; 2011 Feb; 57(2):100, 103. PubMed ID: 21251522
[No Abstract] [Full Text] [Related]
36. Cysteinyl leukotrienes as novel host factors facilitating Cryptococcus neoformans penetration into the brain.
Zhu L; Maruvada R; Sapirstein A; Peters-Golden M; Kim KS
Cell Microbiol; 2017 Mar; 19(3):. PubMed ID: 27573789
[TBL] [Abstract][Full Text] [Related]
37. Role of a CUF1/CTR4 copper regulatory axis in the virulence of Cryptococcus neoformans.
Waterman SR; Hacham M; Hu G; Zhu X; Park YD; Shin S; Panepinto J; Valyi-Nagy T; Beam C; Husain S; Singh N; Williamson PR
J Clin Invest; 2007 Mar; 117(3):794-802. PubMed ID: 17290306
[TBL] [Abstract][Full Text] [Related]
38. Activity of sertraline against Cryptococcus neoformans: in vitro and in vivo assays.
Treviño-Rangel Rde J; Villanueva-Lozano H; Hernández-Rodríguez P; Martínez-Reséndez MF; García-Juárez J; Rodríguez-Rocha H; González GM
Med Mycol; 2016 Mar; 54(3):280-6. PubMed ID: 26705833
[TBL] [Abstract][Full Text] [Related]
39. Decreased resistance to primary intravenous Cryptococcus neoformans infection in aged mice despite adequate resistance to intravenous rechallenge.
Aguirre KM; Gibson GW; Johnson LL
Infect Immun; 1998 Sep; 66(9):4018-24. PubMed ID: 9712741
[TBL] [Abstract][Full Text] [Related]
40. Transcriptomic analysis reveals the relationship of melanization to growth and resistance to gamma radiation in Cryptococcus neoformans.
Schultzhaus Z; Chen A; Kim S; Shuryak I; Chang M; Wang Z
Environ Microbiol; 2019 Aug; 21(8):2613-2628. PubMed ID: 30724440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
